Compare FUN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUN | ABCL |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2023 | 2020 |
| Metric | FUN | ABCL |
|---|---|---|
| Price | $17.97 | $5.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $23.75 | $8.40 |
| AVG Volume (30 Days) | 2.0M | ★ 5.2M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,100,289,000.00 | $75,128,000.00 |
| Revenue This Year | $3.54 | N/A |
| Revenue Next Year | $3.74 | $21.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 14.45 | ★ 160.56 |
| 52 Week Low | $12.51 | $2.75 |
| 52 Week High | $31.25 | $8.44 |
| Indicator | FUN | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 41.04 | 45.36 |
| Support Level | $16.90 | $5.17 |
| Resistance Level | $18.13 | $6.79 |
| Average True Range (ATR) | 0.92 | 0.41 |
| MACD | 0.08 | -0.12 |
| Stochastic Oscillator | 36.15 | 38.46 |
Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS. The parks are family-oriented, with recreational facilities for people of all ages, and provide clean and attractive environments with exciting rides and immersive entertainment. The Company generates revenue from sales of admission to the amusement parks and water parks, from purchases of food, merchandise and games both inside and outside the parks, from the sale of accommodations and other extra-charge.
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.